Dr. Sherrie L Crossen is a Delray Beach, Florida based Periodontics who is specialized in Periodontology. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 505 Ne 3rd St Ste 2, Delray Beach. Patients can reach her at 561-276-3889.
Dr. Sherrie L Crossen is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Dr. Sherrie L Crossen speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Sherrie L Crossen
Specialization:
Periodontics
Gender:
Female
Credentials:
D.D.S., M.S.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
505 Ne 3rd St Ste 2, Delray Beach, Florida, 33483-5541
Phone:
561-276-3889
Fax:
561-276-9930
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3971813965
Enrollment ID:
I20151103001768
NPI Number:
1366570053
NPI Enumeration Date:
02 Mar, 2007
NPI Last Update On:
05 May, 2015
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
505 Ne 3rd St Ste 2, Delray Beach, Florida
Zip:
33483-5541
Phone Number:
561-276-3889
Fax Number:
561-276-9930
Patients can reach Dr. Sherrie L Crossen at 505 Ne 3rd St Ste 2, Delray Beach, Florida or can call to book an appointment on 561-276-3889. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.